|
Market Closed -
Nasdaq
23:00:00 08/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 5.030 USD | -2.52% |
|
-0.40% | -12.82% |
Company Valuation: Unicycive Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 140.1 | - | - |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 12.99% | - | - |
| Enterprise Value (EV) | 30.84 | 8.148 | 30.16 | 82.44 | 124 | 140.1 | 140.1 | 140.1 |
| Change | - | -73.58% | 270.11% | 173.36% | 50.43% | 12.99% | 0% | 0% |
| P/E | -2.4x | -0.45x | -0.68x | -1.42x | -3.46x | -4.16x | 3.12x | 0.68x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0x | -0.1x | 0x | 0x | 0.2x | -0x | 0x |
| Capitalization / Revenue | - | 8.57x | 44.7x | - | - | 509x | 0.96x | 0.29x |
| EV / Revenue | - | 0x | 0x | - | - | 509x | 0.96x | 0.29x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.66x | 2.86x | 0.45x |
| EV / FCF | -0x | - | -0x | -0x | -0x | -4.3x | -6.77x | 0.92x |
| FCF Yield | -18.8% | - | -60.7% | -34.8% | -25.3% | -23.3% | -14.8% | 108% |
| Dividend per Share 2 | - | - | - | - | - | - | 2.08 | 5.37 |
| Rate of return | - | - | - | - | - | - | 41.4% | 107% |
| EPS 2 | -8.6 | -12 | -12.8 | -5.6 | -1.67 | -1.209 | 1.614 | 7.35 |
| Distribution rate | - | - | - | - | - | - | 129% | 73.1% |
| Net sales 1 | - | 0.951 | 0.675 | - | - | 0.2754 | 145.4 | 487.7 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -8.977 | -18.05 | -20.77 | -32.12 | -29.52 | -38.28 | 48.93 | 312.4 |
| Net income 1 | -10.02 | -18.06 | -31.41 | -37.82 | -26.56 | -34.12 | 46.27 | 296.9 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 20.600 | 5.400 | 8.677 | 7.942 | 5.770 | 5.030 | 5.030 | 5.030 |
| Nbr of stocks (in thousands) | 1,497 | 1,509 | 3,475 | 10,380 | 21,491 | 27,855 | - | - |
| Announcement Date | 3/31/22 A | 3/31/23 A | 3/28/24 A | 3/31/25 A | 3/30/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.27x | - | - | - | 144M | |
| 19.9x | 7.03x | 14.13x | 1.49% | 67.82B | |
| 35.92x | 9.37x | 28.59x | 0.04% | 63.22B | |
| -77.3x | 14.92x | -71.95x | -.--% | 27.58B | |
| -15.84x | 6.12x | -7.7x | -.--% | 26.06B | |
| 29.27x | 6.25x | 16.23x | -.--% | 25.38B | |
| 27.11x | 5.08x | 16.9x | -.--% | 19.89B | |
| 49.98x | 18.45x | 37.42x | 0.3% | 17.4B | |
| 1291.85x | 37.31x | 814.25x | -.--% | 14.95B | |
| 18.23x | 5.44x | 12.69x | -.--% | 14.62B | |
| Average | 137.48x | 12.22x | 95.62x | 0.2% | 27.71B | |
| Weighted average by Cap. | 82.32x | 10.32x | 51.78x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- UNCY Stock
- Valuation Unicycive Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
